Abstract:To combine cocktail chemotherapy and photodynamic therapy into one biocompatible and biodegradable nanocarrier, self-assembled DNA nanowires were fabricated and co-loaded with a photosensitizer chlorin e6 (Ce6) and a chemotherapeutic drug doxorubicin (DOX) for antitumor chemophotodynamic combination therapy. Two short DNA chains served as building blocks for the self-assembly of DNA nanowires in a supersandwich hybridization reaction that led to the successful formation of linear DNA nanowires of 500 bases, equal to a length of 167 nm. Ce6 and DOX were loaded onto the nanowires through covalent or noncovalent intercalation interactions, respectively. The DNA nanowires were taken up into cells, and the released Ce6 and DOX were ultimately distributed in different cellular compartments. The photosensitizer-loaded nanowires demonstrated increased generation of photodynamic reactive oxygen species (ROS) compared to that of free Ce6. In comparison with chemo-or photodynamic therapy alone, the combined treatment provided by DNA nanowires loaded with dual-drug significantly increased the incidence of HepG-2 cell death and produced a clear synergistic effect in the treatment of cancer cells. The DNA nanowire nanocarrier provided a flexible and quantitative drug-loading module that allowed for dose control of both drugs. More importantly, the DNA nanowires demonstrate a strong synergistic effect in antitumor chemophotodynamic combination therapy, likely because of increased photodynamic ROS generation and the distribution of Ce6 and DOX in different intracellular compartments. This work suggests that DNA nanowires may be useful as multifunctional and effective therapeutic nanocarriers for chemophotodynamic modalities in cancer therapy.

Novel Carrier-Free, Charge-Reversal and DNA-affinity Nanodrugs for Synergistic Cascade Cancer Chemo-Chemodynamic Therapy.

Mitochondria-acting Carrier-Free Nanoplatform Self-Assembled by Α-Tocopheryl Succinate Carrying Cisplatin for Combinational Tumor Therapy

Nanotrains of DNA Copper Nanoclusters That Triggered a Cascade Fenton-Like Reaction and Glutathione Depletion to Doubly Enhance Chemodynamic Therapy

Co-delivery of Chemotherapeutic Drugs and Immune Adjuvants by Nanoscale DNA Tetrahedrons for Synergistic Cancer Therapy

"Sense-and-treat" DNA Nanodevice for Synergetic Destruction of Circulating Tumor Cells.

Supramolecular-mediated Dual-Functional DNA Nanocomposites for Programmable Cancer Therapy.

A metal ion-drug-induced self-assembly nanosystems for augmented chemodynamic and chemotherapy synergetic anticancer therapy

Multi-Functional Nanodrug Based On A Three-Dimensional Framework For Targeted Photo-Chemo Synergetic Cancer Therapy

Co-administration of a Charge-Conversional Dendrimer Enhances Antitumor Efficacy of Conventional Chemotherapy

Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment

A CDDP-Cross-Linked Nanoprodrug for Combination Therapy Based on Dual-Augmented Cascade Reactions

Intelligent Nanoplatform with Multi Therapeutic Modalities for Synergistic Cancer Therapy

A copper nanocluster-based multifunctional nanoplatform for augmented chemo/chemodynamic/photodynamic combination therapy of breast cancer

Direct Nucleus-Targeted Drug Delivery Using Cascade Phe /photo Dual-Sensitive Polymeric Nanocarrier for Cancer Therapy.

Dual-prodrug cascade activation for chemo/chemodynamic mutually beneficial combination cancer therapy

Dna-Based Ph-Responsive Core-Shell Drug Nanocarrier For Tumor-Targeted Chemo-Photodynamic Therapy

Self-assembled DNA nanowires as quantitative dual-drug nanocarriers for antitumor chemophotodynamic combination therapy

A Novel Strategy to Improve Tumor Targeting of Hydrophilic Drugs and Nanoparticles for Imaging Guided Synergetic Therapy

Boosting Chemodynamic Therapy by Tumor-Targeting and Cellular Redox Homeostasis-Disrupting Nanoparticles.

Cuprous oxide-based nanocrystals with combined chemo/chemodynamic therapy to increase tumor drug sensitivity by reducing mitochondria-derived adenosine-triphosphate

Carrier-free functionalized multidrug nanorods for synergistic cancer therapy